Literature DB >> 23520204

Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1.

Eoin P Brennan1, Karen A Nolan, Emma Börgeson, Oisín S Gough, Caitríona M McEvoy, Neil G Docherty, Debra F Higgins, Madeline Murphy, Denise M Sadlier, Syed Tasadaque Ali-Shah, Patrick J Guiry, David A Savage, Alexander P Maxwell, Finian Martin, Catherine Godson.   

Abstract

Lipoxins, which are endogenously produced lipid mediators, promote the resolution of inflammation, and may inhibit fibrosis, suggesting a possible role in modulating renal disease. Here, lipoxin A4 (LXA4) attenuated TGF-β1-induced expression of fibronectin, N-cadherin, thrombospondin, and the notch ligand jagged-1 in cultured human proximal tubular epithelial (HK-2) cells through a mechanism involving upregulation of the microRNA let-7c. Conversely, TGF-β1 suppressed expression of let-7c. In cells pretreated with LXA4, upregulation of let-7c persisted despite subsequent stimulation with TGF-β1. In the unilateral ureteral obstruction model of renal fibrosis, let-7c upregulation was induced by administering an LXA4 analog. Bioinformatic analysis suggested that targets of let-7c include several members of the TGF-β1 signaling pathway, including the TGF-β receptor type 1. Consistent with this, LXA4-induced upregulation of let-7c inhibited both the expression of TGF-β receptor type 1 and the response to TGF-β1. Overexpression of let-7c mimicked the antifibrotic effects of LXA4 in renal epithelia; conversely, anti-miR directed against let-7c attenuated the effects of LXA4. Finally, we observed that several let-7c target genes were upregulated in fibrotic human renal biopsies compared with controls. In conclusion, these results suggest that LXA4-mediated upregulation of let-7c suppresses TGF-β1-induced fibrosis and that expression of let-7c targets is dysregulated in human renal fibrosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23520204      PMCID: PMC3609134          DOI: 10.1681/ASN.2012060550

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  47 in total

1.  Fast and effective prediction of microRNA/target duplexes.

Authors:  Marc Rehmsmeier; Peter Steffen; Matthias Hochsmann; Robert Giegerich
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

2.  Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs.

Authors:  Yingqing Sun; Seongjoon Koo; Neill White; Eigen Peralta; Christine Esau; Nicholas M Dean; Ranjan J Perera
Journal:  Nucleic Acids Res       Date:  2004-12-22       Impact factor: 16.971

Review 3.  miRNAs, cancer, and stem cell division.

Authors:  Carlo M Croce; George A Calin
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

Review 4.  Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.

Authors:  Charles N Serhan
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2005 Sep-Oct       Impact factor: 4.006

5.  Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy.

Authors:  Holger Schmid; Anissa Boucherot; Yoshinari Yasuda; Anna Henger; Bodo Brunner; Felix Eichinger; Almut Nitsche; Eva Kiss; Markus Bleich; Hermann-Josef Gröne; Peter J Nelson; Detlef Schlöndorff; Clemens D Cohen; Matthias Kretzler
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

6.  Footer: a quantitative comparative genomics method for efficient recognition of cis-regulatory elements.

Authors:  David L Corcoran; Eleanor Feingold; Jessica Dominick; Marietta Wright; Jo Harnaha; Massimo Trucco; Nick Giannoukakis; Panayiotis V Benos
Journal:  Genome Res       Date:  2005-06       Impact factor: 9.043

7.  Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells.

Authors:  Karen Rodgers; Blaithin McMahon; Derick Mitchell; Denise Sadlier; Catherine Godson
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

8.  Expression of types I, II, and III TGF-beta receptors in human glomerulonephritis.

Authors:  T Yamamoto; T Watanabe; N Ikegaya; Y Fujigaki; K Matsui; H Masaoka; M Nagase; A Hishida
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

9.  Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils.

Authors:  S Fiore; S W Ryeom; P F Weller; C N Serhan
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

10.  Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.

Authors:  Sylvie Thuault; Ulrich Valcourt; Maj Petersen; Guidalberto Manfioletti; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  J Cell Biol       Date:  2006-07-10       Impact factor: 10.539

View more
  56 in total

Review 1.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

2.  Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1.

Authors:  Alessandro Matte; Antonio Recchiuti; Enrica Federti; Bérengère Koehl; Thomas Mintz; Wassim El Nemer; Pierre-Louis Tharaux; Valentine Brousse; Immacolata Andolfo; Alessia Lamolinara; Olga Weinberg; Angela Siciliano; Paul C Norris; Ian R Riley; Achille Iolascon; Charles N Serhan; Carlo Brugnara; Lucia De Franceschi
Journal:  Blood       Date:  2018-11-07       Impact factor: 22.113

3.  MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.

Authors:  Anna Maria Pierdomenico; Antonio Recchiuti; Felice Simiele; Marilina Codagnone; Veronica Cecilia Mari; Giovanni Davì; Mario Romano
Journal:  J Biol Chem       Date:  2014-12-11       Impact factor: 5.157

Review 4.  The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis.

Authors:  Takako Nagai; Kyoko Nitta; Megumi Kanasaki; Daisuke Koya; Keizo Kanasaki
Journal:  Clin Exp Nephrol       Date:  2014-07-01       Impact factor: 2.801

5.  Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis.

Authors:  Bo Wang; Kevin Yao; Brooke M Huuskes; Hsin-Hui Shen; Junli Zhuang; Catherine Godson; Eoin P Brennan; Jennifer L Wilkinson-Berka; Andrea F Wise; Sharon D Ricardo
Journal:  Mol Ther       Date:  2016-05-18       Impact factor: 11.454

Review 6.  Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.

Authors:  Wenshan Lv; Fan Fan; Yangang Wang; Ezekiel Gonzalez-Fernandez; Chen Wang; Lili Yang; George W Booz; Richard J Roman
Journal:  Physiol Genomics       Date:  2017-11-10       Impact factor: 3.107

7.  Emerging role of miRNAs in renal fibrosis.

Authors:  Youling Fan; Hongtao Chen; Zhenxing Huang; Hong Zheng; Jun Zhou
Journal:  RNA Biol       Date:  2019-09-24       Impact factor: 4.652

8.  Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.

Authors:  Eoin P Brennan; Muthukumar Mohan; Aaron McClelland; Christos Tikellis; Mark Ziemann; Antony Kaspi; Stephen P Gray; Raelene Pickering; Sih Min Tan; Syed Tasadaque Ali-Shah; Patrick J Guiry; Assam El-Osta; Karin Jandeleit-Dahm; Mark E Cooper; Catherine Godson; Phillip Kantharidis
Journal:  J Am Soc Nephrol       Date:  2018-02-28       Impact factor: 10.121

Review 9.  Thrombospondin-1 interactions regulate eicosanoid metabolism and signaling in cancer-related inflammation.

Authors:  Manuel U Ramirez; Elizabeth R Stirling; Nancy J Emenaker; David D Roberts; David R Soto-Pantoja
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

10.  BML-111 Attenuates Renal Ischemia/Reperfusion Injury Via Peroxisome Proliferator-Activated Receptor-α-Regulated Heme Oxygenase-1.

Authors:  Sheng-Hua Wu; Xiao-Qing Chen; Jing Lü; Ming-Jie Wang
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.